BioSpace News Archive

Recommendations align with protocols outlined in ImpediMed’s Lymphedema Prevention Program [13-February-2020] CARLSBAD, Calif. , and BRISBANE, Australia , Feb. 13, 2020 /PRNewswire/ -- ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscop

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced its financial results for the three and six months ended December 31, 2019 and provided a corporate update.

Co-Diagnostics, Inc. (Nasdaq: CODX), announced today that it has been invited to be a featured speaker to present its rapid response to the new coronavirus (Covid-19) global health concern, as well as its multiplex PCR solutions for mosquito-borne diseases, at the 3rd International Conference on Zika Virus and Aedes Related Infections.

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Amber Salzman, Ph.D., to the Company’s Board of Directors, expanding the board to 11 members.

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its RiVax

Gossamer Bio, Inc. (Nasdaq: GOSS), today announced that it will present two posters with data on its GB004 program at the 15th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO) being held February 12- 15 in Vienna, Austria.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), announced today that its fourth quarter and full year 2019 financial results will be released after the market closes on Thursday, February 20, 2020.

As part of its continued global expansion, Glooko, the leader in diabetes digital health and data management solutions, today announced the appointment of Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer

Sinclair Research, one of the leading providers of nonclinical research services, has named Ian Vanterpool as Vice President of Operations.

Feb. 13, 2020 13:00 UTC FORT LAUDERDALE, Fla.--( BUSINESS WIRE )-- Motus GI Holdings, Inc. , (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its chief executive officer, Tim Moran, will present an overview of the Pure-Vu ® System and participate in a panel discussi